Epithelial-to-mesenchymal transdifferentiation of renal tubular epithelial cell mediated by oxidative stress and intervention effect of probucol in diabetic nephropathy rats

Renal Failure

Volumn 34, Issue 10, 2012, Pages 1244-1251

  Duan, Shao Bin ^a   Liu, Gai Ling ^a   Wang, Yu Hui ^a   Zhang, Jing Jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Diabetes; Epithelial to mesenchymal transdifferentiation; Oxidative stress; Probucol; Renal tubular epithelial cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROBUCOL; TRANSCRIPTION FACTOR SP1; TRIACYLGLYCEROL; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL TRANSDIFFERENTIATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KIDNEY TUBULE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY TUBULES; MALE; OXIDATIVE STRESS; PROBUCOL; RATS; RATS, SPRAGUE-DAWLEY; UROTHELIUM;

EID: 84867694711     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2012.718711     Document Type: Article

References (26)

1. Soldatos G, Cooper ME. Diabetic nephropathy: Important pathophysiologic mechanisms. Diabetes Res Clin Pract. 2008;82 (Suppl. 1):S75-"79.
2. Hills CE, Squires PE. The role of TGF-beta and epithelial-tomesenchymal transition in diabetic nephropathy. Cytokine Growth Factor Rev. 2011;22:131-"139.
3. Hills CE, Al-Rasheed N, Al-Rasheed N, Willars GB, Brunskill NJ. C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: Implications for treatment of diabetic nephropathy. Am J Physiol Renal Physiol. 2009;296:F614-"F621.
4. Hills CE, Squires PE. TGF-beta1-induced epithelial-tomesenchymal transition and therapeutic intervention in diabetic nephropathy. Am J Nephrol. 2010;31:68-"74.
5. Zhou Y, Liao Q, Luo Y, Qing Z, Zhang Q, He G. Renal protective effect of Rosa laevigata Michx by the inhibition of oxidative stress in streptozotocin-induced diabetic rats. Mol Med Report. 2012;5:1548-"1554.
6. Sanchez AP, Sharma K. Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev Mol Med. 2009; 11:e13.
7. Kang MY, Park YH, Kim BS, Seo SY. Preventive effects of green tea (Camellia Sinensis var. Assamica) on diabetic nephropathy. Yonsei Med J. 2012;53:138-"144.
8. Du J, Wang L, Liu X, et al. Janus kinase 2/signal transducers and activators of transcription signal inhibition regulates protective effects of probucol on mesangial cells treated with high glucose. Biol Pharm Bull. 2010;33:768-"772.
9. Atsumi H, Kitada M, Kanasaki K, Koya D. Reversal of redoxdependent inhibition of diacylglycerol kinase by antioxidants in mesangial cells exposed to high glucose. Mol Med Report. 2011;4:923-"927.
10. Endo K, Miyashita Y, Sasaki H, et al. Probucol delays progression of diabetic nephropathy. Diabetes Res Clin Pract. 2006;71:156-"163. (Pubitemid 43112107)
11. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol. 2003;14:S250-"S253. (Pubitemid 36903935)
12. Tesch GH, Nikolic-Paterson DJ. Recent insights into experimental mouse models of diabetic nephropathy. Nephron. 2006;104:e57-"e62. (Pubitemid 44450472)
13. Wang H, Li J, Yu L, Zhao Y, Ding W. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci. 2004;74:1645-"1658. (Pubitemid 38114793)
14. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev. 2008;4:39-"45. (Pubitemid 351210971)
15. Kashihara N, Haruna Y, Kondeti VK, Kanwar YS. Oxidative stress in diabetic nephropathy. Curr Med Chem. 2010;17: 4256-"4269.
16. Rhyu DY, Yang Y, Ha H, et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-Activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol. 2005;16: 667-"675. (Pubitemid 41725103)
17. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev (Orlando). 2008;22:1-"5. (Pubitemid 350131582)
18. Djamali A, Vidyasagar A, Adulla M, Hullett D, Reese S. Nox-2 is a modulator of fibrogenesis in kidney allografts. Am J Transplant. 2009;9:74-"82.
19. Zhang A, Jia Z, Guo X, Yang T. Aldosterone induces epithelialmesenchymal transition via ROS of mitochondrial origin. Am J Physiol. 2007;293:F723- "F731. (Pubitemid 47403342)
20. Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, Liu RM. Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol. 2007;293:L1281-"L1292. (Pubitemid 350159412)
21. Kang JH, Chae YM, Park KK, Kim CH, Lee IS, Chang YC. Suppression of mesangial cell proliferation and extracellular matrix production in streptozotocin-induced diabetic rats by Sp1 decoy oligodeoxynucleotide in vitro and in vivo. J Cell Biochem. 2008;103:663-"674.
22. De Haan JB, Crack PJ, Flentjar N, Iannello RC, Hertzog PJ, Kola I. An imbalance in antioxidant defense affects cellular function: The pathophysiological consequences of a reduction in antioxidant defense in the glutathione peroxidase-1 (gpx1) knockout mouse. Redox Rep. 2003;8: 69-"79. (Pubitemid 36511762)
23. Kornhauser C, Garcia-Ramirez JR, Wrobel K, Perez-Luque EL, Garay-Sevilla ME, Wrobel K. Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim Care Diabetes. 2008;2:81-"85.
24. Lee EA, Seo JY, Jiang Z, et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 upregulation in mesangial cells and in diabetic kidney. Kidney Int. 2005;67:1762-"1771. (Pubitemid 40577711)
25. Kondo S, Shimizu M, Urushihara M, et al. Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat. J Am Soc Nephrol 2006;17: 783-"794.
26. Li G, Yin L, Liu T, et al. Role of probucol in preventing contrastinduced acute kidney injury after coronary interventional procedure. Am J Cardiol. 2009;103:512-"514.